LILRB2 and inflammatory bowel disease: Notably, when we examined the same IBD patient cohort used in the above analysis, Spearman’s correlation demonstrated a significant positive correlation between PFKFB3 and CXCL5, CXCL11, LILRB2, CD86, CXCL6, CD274, TNIP3, CD40, CCL24, REG3A expression.